Viewing Study NCT00690066


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-04-13 @ 10:46 AM
Study NCT ID: NCT00690066
Status: COMPLETED
Last Update Posted: 2021-12-23
First Post: 2008-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Sponsor: Mesoblast, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes Mellitus View
None Type 1 Diabetes View
None Diabetes Mellitus, Insulin-Dependent View
None Juvenile Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T1DM View
None Type 1 Diabetes Mellitus View
None Type 1 Diabetes View
None Diabetes Mellitus, Insulin-Dependent View
None Juvenile Diabetes View
None Adult Human Stem Cells View
None Mesenchymal Stem Cells View
None MSCs View
None Insulin View
None Osiris View
None Prochymal View